374 results
8-K
SEEL
Seelos Therapeutics Inc
3 May 24
Entry into a Material Definitive Agreement
5:06pm
. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects or future events, as well as words such as “believes
S-8
EX-5.1
SEEL
Seelos Therapeutics Inc
6 Mar 24
Registration of securities for employees
5:38pm
, including an examination of originals or copies certified or otherwise identified to our satisfaction as being true copies of (i) the Registration Statement
8-K
EX-4.1
8zluvdehx
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
2q96lwsp
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-5.1
lkv vc0yh6qs0gfo
30 Jan 24
Entry into a Material Definitive Agreement
4:01pm
424B5
yvw1bodkiy gk48
30 Jan 24
Prospectus supplement for primary offering
6:05am
8-K
EX-4.2
26q9c0x6qosk3
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
8-K
EX-99.1
aisj7b w6
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
8-K
EX-5.2
1loe3uq6gr8f ljrhjq
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
8-K
i1d5408jvd4
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
8-K
EX-4.1
h75 28xozhn
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm